LYNN BAXTER
CEO
Lynn joined the GSK Executive Committee in 2026. She became Chief Executive Officer of ViiV Healthcare on 1 November 2026. In addition to leadership of the HIV business, Lynn also leads GSK's Global Health organisation.
Lynn brings a proven track record of impact over almost three decades of global experience across pharmaceuticals and vaccines, having held senior leadership roles in the USA, Europe, and Asia.
Previously, Lynn was President, Europe, for GSK where she was responsible for the commercial performance and strategic direction of GSK’s European markets, overseeing a diverse range of medicines and vaccines across more than 30 countries. Before this, Lynn led the ViiV North America business for six years. Under her leadership, the team delivered strong performance with sustained double-digit growth, successfully executing four paradigm-shifting launches in HIV treatment and prevention.
During her career with GSK and ViiV, Lynn has also been SVP Head of Global Product Strategy for Vaccines at GSK, overseeing global strategy for a broad portfolio and pipeline. She has also served as General Manager for GSK Philippines and held commercial leadership roles in Emerging Markets and Asia Pacific, China, and global marketing. Before joining GSK in 2009, Lynn progressed through positions of increasing seniority at Roche Pharmaceuticals and Merck Sharp & Dohme.
Our Executive Team
Our Board of Directors
YOU MAY ALSO BE INTERESTED IN
Together we are engaged in the HIV response throughout the world, supported by a team of over 1,100 dedicated ViiV Healthcare staff working across the globe.
Discover more about who we are, the work we do and what we're doing to advance HIV science, support the delivery of HIV treatment and care; and work with partners to address the stigma and discrimination faced by people living with HIV.
NP-GBL-HVX-COCO-220025 November 2026
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.
